Global Oncology Based In-Vivo CRO Market Size, Share, Trends, Growth and Forecast 2032

• Chapter 1. Preface
  • 1.1. Report Description and Scope
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology
• Chapter 2. Executive Summary
  • 2.1. Onculogy Based In-Vivo CRO Market, 2015–2025 (USD Billion)
  • 2.2. Onculogy Based In-Vivo CRO Market: Snapshot
• Chapter 3. Global Onculogy Based In-Vivo CRO Market– Industry Analysis
  • 3.1. Onculogy Based In-Vivo CRO Market: Market Dynamics
  • 3.2. Market Drivers
    • 3.2.1. A surge in the aging population prone to chronic diseases such as cancer is likely to define the expansion of onculogy based in-vivo CRO industry over the forecast timeframe.
    • 3.2.2. Approval of generic medicines by organizations such as U.S. FDA and launch of biosimilars has encouraged the pharma firms to take support of CROs for cancer research & drug development. Such moves will create a strong platform for the growth of the onculogy based in-vivo CRO industry over the assessment period.
  • 3.3. Porter’s Five Forces Analysis
  • 3.4. Market Attractiveness Analysis
    • 3.4.1. Market attractiveness analysis By Indication
• Chapter 4. Global Onculogy Based In-Vivo CRO Market– Competitive Landscape
  • 4.1. Company market share analysis
    • 4.1.1. Global Onculogy Based In-Vivo CRO Market: company market share, 2018
  • 4.2. Strategic development
    • 4.2.1. Acquisitions & mergers
    • 4.2.2. New Product launches
    • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
    • 4.2.4. Research and development and Regional expansion
  • 4.3. Price trend analysis
• Chapter 5. Global Onculogy Based In-Vivo CRO Market– Indication Analysis
  • 5.1. Global Onculogy Based In-Vivo CRO Market overview: By Indication
    • 5.1.1. Global Onculogy Based In-Vivo CRO Market share, By Indication , 2019 and 2025
  • 5.2. Sulid Tumors
    • 5.2.1. Global Onculogy Based In-Vivo CRO Market By Sulid Tumors , 2015–2025 (USD Billion)
  • 5.3. Blood Cancer
    • 5.3.1. Global Onculogy Based In-Vivo CRO Market By Blood Cancer, 2015–2025 (USD Billion)
  • 5.4. Patient-Derived Xenograft
    • 5.4.1. Global Onculogy Based In-Vivo CRO Market By Patient-Derived Xenograft , 2015–2025 (USD Billion)
  • 5.5. Syngeneic Model
    • 5.5.1. Global Onculogy Based In-Vivo CRO Market By Syngeneic Model, 2015–2025 (USD Billion)
  • 5.6. Xenograft
    • 5.6.1. Global Onculogy Based In-Vivo CRO Market By Xenograft, 2015–2025 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Onculogy Based In-Vivo CRO Market By Others, 2015–2025 (USD Billion)
• Chapter 6. Company Profiles
  • 6.1. Charles River Laboratory
    • 6.1.1. Overview
    • 6.1.2. Financials
    • 6.1.3. Product Portfolio
    • 6.1.4. Business Strategy
    • 6.1.5. Recent Developments
  • 6.2. Eurofins Scientific
    • 6.2.1. Overview
    • 6.2.2. Financials
    • 6.2.3. Product Portfolio
    • 6.2.4. Business Strategy
    • 6.2.5. Recent Developments
  • 6.3. Crown Bioscience
    • 6.3.1. Overview
    • 6.3.2. Financials
    • 6.3.3. Product Portfolio
    • 6.3.4. Business Strategy
    • 6.3.5. Recent Developments
  • 6.4. ICON Plc.
    • 6.4.1. Overview
    • 6.4.2. Financials
    • 6.4.3. Product Portfolio
    • 6.4.4. Business Strategy
    • 6.4.5. Recent Developments
  • 6.5. The Jackson Laboratory
    • 6.5.1. Overview
    • 6.5.2. Financials
    • 6.5.3. Product Portfolio
    • 6.5.4. Business Strategy
    • 6.5.5. Recent Development
  • 6.6. EVOTEC
    • 6.6.1. Overview
    • 6.6.2. Financials
    • 6.6.3. Product Portfolio
    • 6.6.4. Business Strategy
    • 6.6.5. Recent Development
  • 6.7. Covance
    • 6.7.1. Overview
    • 6.7.2. Financials
    • 6.7.3. Product Portfolio
    • 6.7.4. Business Strategy
    • 6.7.5. Recent Development
  • 6.8. Taconic Biosciences
    • 6.8.1. Overview
    • 6.8.2. Financials
    • 6.8.3. Product Portfolio
    • 6.8.4. Business Strategy
    • 6.8.5. Recent Development
  • 6.9. Wuxi AppTec
    • 6.9.1. Overview
    • 6.9.2. Financials
    • 6.9.3. Product Portfolio
    • 6.9.4. Business Strategy
    • 6.9.5. Recent Development
  • 6.10. Living Tumor Laboratory
    • 6.10.1. Overview
    • 6.10.2. Financials
    • 6.10.3. Product Portfolio
    • 6.10.4. Business Strategy
    • 6.10.5. Recent Development
  • 6.11. MI Bioresearch, Inc.
    • 6.11.1. Overview
    • 6.11.2. Financials
    • 6.11.3. Product Portfolio
    • 6.11.4. Business Strategy
    • 6.11.5. Recent Development
  • 6.12. Xentech
    • 6.12.1. Overview
    • 6.12.2. Financials
    • 6.12.3. Product Portfolio
    • 6.12.4. Business Strategy
    • 6.12.5. Recent Development
  • 6.13. Champion Onculogy, Inc.
    • 6.13.1. Overview
    • 6.13.2. Financials
    • 6.13.3. Product Portfolio
    • 6.13.4. Business Strategy
    • 6.13.5. Recent Development

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global Oncology Based In-Vivo CRO Market, 2015–2025 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global Oncology Based In-Vivo CRO Market attractiveness, By Indication  
6. Global Oncology Based In-Vivo CRO Market Share by Indication  ,2019 and 2025 (USD Billion)
7. Global Oncology Based In-Vivo CRO Market by Solid Tumors ,2015–2025 (USD Billion)
8. Global Oncology Based In-Vivo CRO Market by Blood Cancer ,2015–2025 (USD Billion)
9. Global Oncology Based In-Vivo CRO Market by Patient-Derived Xenograft ,2015–2025 (USD Billion)
10. Global Oncology Based In-Vivo CRO Market by Syngeneic Model,2015–2025 (USD Billion)
11. Global Oncology Based In-Vivo CRO Market by Xenograft ,2015–2025 (USD Billion)
12. Global Oncology Based In-Vivo CRO Market by Others ,2015–2025 (USD Billion)
13. Global Oncology Based In-Vivo CRO Market share, by Region, 2019 and 2025
14. North America Oncology Based In-Vivo CRO Market, 2015–2025 (USD Billion)
15. Europe Oncology Based In-Vivo CRO Market, 2015–2025 (USD Billion)
16. Asia Pacific Oncology Based In-Vivo CRO Market, 2015–2025 (USD Billion)
17. Latin America Oncology Based In-Vivo CRO Market, 2015–2025 (USD Billion)
18. The Middle East and Africa Oncology Based In-Vivo CRO Market, 2015–2025 (USD Billion)
 

Table Of Tables

List of Tables

1. Global Oncology Based In-Vivo CRO Market: snapshot
2. Drivers of the Oncology Based In-Vivo CRO Market: impact analysis
3. North America Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
4. The U.S. Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
5. Rest of North America Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
6. Europe Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
7. UK Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
8. France Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
9. Germany Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
10. Rest of Europe Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
11. Asia Pacific Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
12. China Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
13. Japan Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
14. India Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
15. Rest of Asia Pacific Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
16. Latin America Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
17. Brazil Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
18. Rest of Latin America Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
19. The Middle East and Africa Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
20. Saudi Arabia Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
21. South Africa Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
22. Rest of the Middle East & Africa Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
23. Rest of the Middle East & Africa Oncology Based In-Vivo CRO Market revenue, By Mechanism Of Action , 2015–2025 (USD Billion)